‘I Smuggled Code’: An Executive’s Admission in Heated Brokerage Feud
A former executive at StoneX Group Inc. admitted to stealing trade secrets from his prior employer BTIG LLC, a surprise twist ...
Aclaris stock soars for second day on licensing deal, analyst upgrades
Aclaris (ACRS) soared 60% Tuesday, the day after the company announced it was licensing two drug candidates, prompting ...
RealReal price target raised to $5.50 from $4 at BTIG
BTIG analyst Marvin Fong raised the firm’s price target on RealReal (REAL) to $5.50 from $4 and keeps a Buy rating on the shares. The firm ...
Le Lézard17h
Simulations Plus to Participate in the BTIG Digital Health Forum
Simulations Plus, Inc. ("Simulations Plus"), a leading provider of biosimulation, simulation-enabled performance and intelligence solutions, and medical communications for the biopharma industry, ...
Fintel on MSN19h
BTIG Upgrades Aclaris Therapeutics (ACRS)
Fintel reports that on November 19, 2024, BTIG upgraded their outlook for Aclaris Therapeutics (NasdaqGS:ACRS) from Neutral ...
Business Insider19h
Bitdeer management to meet virtually with BTIG
Energy and Infrastructure Transition Analyst Lewis holds a virtual meeting with management on November 22 hosted by BTIG. Don't Miss out on Research Tools: Discover the latest stocks recommended by ...